J&J AngioGuard Emboli Capture Device Purchase Portends SMART Bundle
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials of Johnson & Johnson's SMART stent for carotid revascularization procedures and AngioGuard's emboli capture device could dovetail following J&J's acquisition of the Minneapolis-based start-up, announced July 7.
You may also be interested in...
PercuSurge Committed To Boston Scientific Carotid Stent Trial
PercuSurge will proceed with plans to conduct U.S. trials of its GuardWire distal protection device with Boston Scientific's WallStent for carotid angioplasty, in spite of rival Medtronic's proposed purchase of the company for $225 mil., announced Oct. 19.
PercuSurge Committed To Boston Scientific Carotid Stent Trial
PercuSurge will proceed with plans to conduct U.S. trials of its GuardWire distal protection device with Boston Scientific's WallStent for carotid angioplasty, in spite of rival Medtronic's proposed purchase of the company for $225 mil., announced Oct. 19.
Boston Scientific Embol-X Buy Readies Firm For Carotid Stent Race
Boston Scientific's acquisition of embolic protection technology developed by Embol-X may help level the playing field with competitors Guidant and Johnson & Johnson in the race to bring carotid stent technology to market.